Published : Sep-2017
No. of Pages : 50
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Osteoarthritis: Executive Summary 5
2.1 Related Reports 8
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.3 Global and Historical Trends 11
3.4 Forecast Methodology 14
3.4.1 Sources 15
3.4.2 Forecast Assumptions and Methods 20
3.5 Epidemiological Forecast for OA (2016-2026) 26
3.5.1 Total Prevalent Cases (Radiographic) of Hand OA 26
3.5.2 Total Prevalent Cases (Symptomatic) of Hand OA 26
3.5.3 Diagnosed Prevalent Cases (Symptomatic) of Hand OA 27
3.5.4 Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA 28
3.5.5 Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA 28
3.5.6 Diagnosed Prevalent Cases (Symptomatic) of Hand OA by Severity 29
3.5.7 Total Prevalent Cases (Radiographic) of Knee OA 30
3.5.8 Total Prevalent Cases (Symptomatic) of Knee OA 31
3.5.9 Diagnosed Prevalent Cases (Symptomatic) of Knee OA 32
3.5.10 Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA 33
3.5.11 Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA 34
3.5.12 Diagnosed Prevalent Cases (Symptomatic) of Knee OA by Severity 35
3.5.13 Total Prevalent Cases (Radiographic) of Hip OA 36
3.5.14 Total Prevalent Cases (Symptomatic) of Hip OA 37
3.5.15 Diagnosed Prevalent Cases (Symptomatic) of Hip OA 38
3.5.16 Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA 39
3.5.17 Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA 40
3.5.18 Diagnosed Prevalent Cases (Symptomatic) of Hip OA by Severity 41
3.6 Discussion 42
3.6.1 Epidemiological Forecast Insight 42
3.6.2 Limitations of Analysis 42
3.6.3 Strengths of Analysis 43
4 Appendix 44
4.1 Bibliography 44
4.2 High-Prescribing Physician Survey 47
4.3 About the Authors 48
4.3.1 Epidemiologist 48
4.3.2 Reviewers 48
4.3.3 Global Director of Therapy Analysis and Epidemiology 49
4.3.4 Global Head and EVP of Healthcare Operations and Strategy 49
4.4 About GlobalData 50
4.5 Contact Us 50
4.6 Disclaimer 50
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for OA 11
Table 2: Severity Scoring System for Classifying the Hand, Knee, and Hip OA Using the KL Grading Scale. 15
Table 3: 7MM, Total Prevalent Cases (Radiographic) of Hand OA, Both Sexes, Ages =18 Years, N, Selected Years 2016-2026 26
Table 4: 7MM, Total Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages =18 Years, N, Selected Years 2016-2026 27
Table 5: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages =18 Years, N, Selected Years 2016-2026 27
Table 6: 7MM, Total Prevalent Cases (Radiographic) of Knee OA, Both Sexes, Ages =18 Years, N, Selected Years 2016-2026 31
Table 7: 7MM, Total Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages =18 Years, N, Selected Years 2016-2026 31
Table 8: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages =18 Years, N, Selected Years 2016-2026 32
Table 9: 7MM, Total Prevalent Cases (Radiographic) of Hip OA, Both Sexes, Ages =18 Years, N, Selected Years 2016-2026 36
Table 10: 7MM, Total Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages =18 Years, N, Selected Years 2016-2026 37
Table 11: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages =18 Years, N, Selected Years 2016-2026 38
Table 12: High-Prescribing Physicians (Non-KOLs), Surveyed by Country, 2017 47
1.2 List of Figures
Figure 1: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages =18 Years, 2016 and 2026 6
Figure 2: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages =18 Years, 2016 and 2026 7
Figure 3: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages =18 Years, 2016 and 2026 8
Figure 4: 7MM, Age-Standardized Diagnosed Prevalence (Symptomatic) (%), Hand OA, Men and Women, Ages =18 Years, 2016 12
Figure 5: 7MM, Age-Standardized Diagnosed Prevalence (Symptomatic) (%), Knee OA, Men and Women, Ages =18 Years, 2016 13
Figure 6: 7MM, Age-Standardized Diagnosed Prevalence (Symptomatic) (%), Hip OA, Men and Women, Ages =18 Years, 2016 14
Figure 7: 7MM, Sources Used to Forecast Total Prevalent Cases (Radiographic), Hand OA 15
Figure 8: 7MM, Sources Used to Forecast Total Prevalent Cases (Symptomatic), Hand OA 16
Figure 9: 7MM, Sources Used to Forecast Total Prevalent Cases (Radiographic), Knee OA 17
Figure 10: 7MM, Sources Used to Forecast Total Prevalent Cases (Symptomatic), Knee OA 18
Figure 11: 7MM, Sources Used to Forecast Total Prevalent Cases (Radiographic), Hip OA 19
Figure 12: 7MM, Sources Used to Forecast Total Prevalent Cases (Symptomatic), Hip OA 20
Figure 13: 7MM, Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages =18 Years, N, 2016 28
Figure 14: 7MM, Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages =18 Years, N, 2016 29
Figure 15: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hand OA by Severity, Both Sexes, Ages =18 Years, N, 2016 30
Figure 16: 7MM, Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages =18 Years, N, 2016 33
Figure 17: 7MM, Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages =18 Years, N, 2016 34
Figure 18: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Knee OA by Severity, Both Sexes, Ages =18 Years, N, 2016 35
Figure 19: 7MM, Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages =18 Years, N, 2016 39
Figure 20: 7MM, Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages =18 Years, N, 2016 40
Figure 21: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hip OA by Severity, Both Sexes, Ages =18 Years, N, 2016 41
